Your browser is no longer supported. Please, upgrade your browser.
Settings
GNVC GenVec, Inc. daily Stock Chart
GNVC [NASD]
GenVec, Inc.
Index- P/E- EPS (ttm)-0.41 Insider Own1.10% Shs Outstand23.77M Perf Week6.25%
Market Cap16.16M Forward P/E- EPS next Y-0.32 Insider Trans1.95% Shs Float19.37M Perf Month-29.17%
Income-6.90M PEG- EPS next Q-0.07 Inst Own14.10% Short Float1.33% Perf Quarter33.33%
Sales0.80M P/S20.20 EPS this Y-145.50% Inst Trans-38.76% Short Ratio1.64 Perf Half Y-62.01%
Book/sh0.35 P/B1.94 EPS next Y-6.70% ROA-68.50% Target Price5.00 Perf Year-68.95%
Cash/sh0.29 P/C2.34 EPS next 5Y35.00% ROE-83.20% 52W Range0.35 - 3.69 Perf YTD-63.04%
Dividend- P/FCF- EPS past 5Y16.60% ROI-85.30% 52W High-81.57% Beta2.32
Dividend %- Quick Ratio4.80 Sales past 5Y-44.30% Gross Margin- 52W Low94.29% ATR0.10
Employees15 Current Ratio4.80 Sales Q/Q-25.00% Oper. Margin- RSI (14)47.71 Volatility9.04% 15.50%
OptionableNo Debt/Eq0.00 EPS Q/Q-16.60% Profit Margin- Rel Volume0.51 Prev Close0.62
ShortableYes LT Debt/Eq0.00 EarningsMay 12 BMO Payout- Avg Volume157.64K Price0.68
Recom2.00 SMA20-5.23% SMA50-10.97% SMA200-51.76% Volume80,200 Change9.68%
Feb-24-14Initiated HC Wainwright Buy $9
May-20-16 01:04PM  GENVEC INC Financials
May-17-16 12:49PM  GenVec, Inc. :GNVC-US: Earnings Analysis: Q1, 2016 By the Numbers -5.71%
May-12-16 11:14AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -5.80%
08:00AM  GenVec Reports First Quarter 2016 Financial Results PR Newswire
May-10-16 05:48PM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Fi +5.56%
May-09-16 08:10AM  7 Stocks Under $10 Spiking Toward Big Gains at TheStreet
May-05-16 08:55AM  GenVec Announces $5 Million At-The-Market Offering PR Newswire -18.82%
May-02-16 09:29AM  GENVEC INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  GenVec Provides Update on Hearing Loss Clinical Program PR Newswire
Mar-14-16 10:49AM  GenVec, Inc. :GNVC-US: Earnings Analysis: Q4, 2015 By the Numbers -5.97%
Mar-09-16 08:01AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +55.10%
07:30AM  GenVec Reports Fourth Quarter and 2015 Year-End Financial Results PR Newswire
07:07AM  Q4 2015 GenVec Inc Earnings Release - Before Market Open
Mar-02-16 08:00AM  GenVec To Release Fourth Quarter And Year-End 2015 Financial Results And Conduct A Conference Call On March 9, 2016 PR Newswire +6.12%
Feb-26-16 05:21PM  GENVEC INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transf
Jan-22-16 04:07PM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
Jan-20-16 07:00AM  GenVec Provides Investor Update PR Newswire
Jan-11-16 12:55PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of GenVec, Inc. (GNVC) -58.38%
08:11AM  GENVEC INC Files SEC form 8-K, Other Events
Jan-07-16 02:51PM  GenVec returns to hearing loss research with new Novartis deal at bizjournals.com
Dec-10-15 11:51AM  GenVec, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-09-15 01:56PM  Is GenVec, Inc. (GNVC) A Good Stock To Buy? at Insider Monkey
Dec-02-15 08:00AM  GenVec Receives Notice of Allowance for Patent Application Providing Broad Protection of Its Gorilla Adenovectors PR Newswire
Nov-16-15 04:45PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; C -7.69%
Nov-09-15 09:57AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  GenVec Reports Third Quarter 2015 Financial Results PR Newswire
Nov-04-15 08:00AM  GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference PR Newswire
Oct-02-15 10:51AM  GenVec, Inc. Earnings Q2, 2015
Sep-30-15 08:00AM  GenVec To Present At 2015 Stem Cell Meeting On The Mesa PR Newswire
Sep-28-15 08:00AM  GenVec Expands I.P. Portfolio With Issuance Of U.S. And European Patents For Monkey Adenoviral Vectors PR Newswire
Sep-21-15 08:51AM  GenVec (GNVC) Shows Strength: Stock Moves Up 18.7% -5.82%
Aug-10-15 08:13PM  10-Q for GenVec, Inc. at Company Spotlight
Aug-07-15 10:37AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:00AM  GenVec Reports Second Quarter 2015 Financial Results PR Newswire
Jun-03-15 08:00AM  GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines PR Newswire
May-28-15 08:00AM  GenVec To Present At The Jefferies Healthcare Conference PR Newswire +7.31%
May-14-15 08:00AM  GenVec Highlights Proprietary Gorilla Vectors At ASGCT Presentation PR Newswire
May-10-15 08:11PM  10-Q for GenVec, Inc. at Company Spotlight
May-08-15 09:48AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:30AM  GenVec Reports First Quarter 2015 Financial Results PR Newswire
May-01-15 08:11PM  10-K for GenVec, Inc. at Company Spotlight
Apr-23-15 01:57PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers
Apr-22-15 08:25AM  Michael Richman Appointed To GenVec Board Of Directors at noodls
08:00AM  Michael Richman Appointed To GenVec Board Of Directors PR Newswire
Apr-21-15 08:29AM  GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology at noodls +5.69%
08:01AM  GenVec Announces Collaboration with the Laboratory of Malaria Immunology & Vaccinology PR Newswire
Apr-16-15 02:57PM  Bristol-Myers Deal Flags Three Gene-Therapy Picks at Barrons.com
Mar-30-15 09:07AM  GenVec to Release Fourth Quarter and Year-End 2014 Financial Results and Conduct a Conference Call on March 24, 2015 at noodls -5.16%
09:07AM  GenVec To Present At The 27th Annual ROTH Conference at noodls
09:07AM  GenVec Reports Fourth Quarter And 2014 Year-End Financial Results at noodls
09:07AM  GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies at noodls
Mar-24-15 10:00AM  GenVec Inc Earnings Call scheduled for 10:00 am ET today
08:40AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2014 GenVec Inc Earnings Release - Before Market Open
07:00AM  GenVec Reports Fourth Quarter And 2014 Year-End Financial Results PR Newswire
Mar-23-15 07:00AM  GenVec and TheraBiologics form Collaboration to Develop Neural Stem Cell Mediated Cancer Therapies PR Newswire
Mar-17-15 08:00AM  GenVec to Release Fourth Quarter and Year-End 2014 Financial Results and Conduct a Conference Call on March 24, 2015 PR Newswire
Mar-02-15 08:00AM  GenVec To Present At The 27th Annual ROTH Conference PR Newswire
Feb-25-15 11:02AM  Video Interview: Doug Swirsky, Chief Executive Officer, GenVec, Inc. [GNVC] GlobeNewswire
Feb-02-15 08:00AM  GenVec To Present At The 17th Annual BIO CEO & Investor Conference PR Newswire +14.45%
Jan-07-15 07:00PM  Lady Gaga at High Volume Drives Hearing-Loss Drug Search: Health at Bloomberg +23.68%
Dec-09-14 04:53PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security
Nov-14-14 07:09PM  10-Q for GenVec, Inc. Company Spotlight
Nov-12-14 09:29AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:18AM  GenVec Reports Third Quarter 2014 Financial Results at noodls
07:55AM  GenVec Reports Third Quarter 2014 Financial Results PR Newswire
Nov-11-14 07:30AM  Preclinical Data For GenVec's RSV Vaccine Candidate Presented At The 9th RSV Symposium PR Newswire +8.84%
Nov-05-14 07:15AM  GenVec Achieves Milestone In Hearing And Balance Collaboration PR Newswire
Nov-03-14 04:16PM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +7.45%
Oct-31-14 07:30AM  Quinterol Mallette Appointed to GenVec Board Of Directors PR Newswire
Oct-29-14 06:30AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Oct-20-14 09:27AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:00AM  Zola P. Horovitz To Retire From GenVec Board PR Newswire
Aug-12-14 09:42AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:30AM  GenVec Reports Second Quarter 2014 Financial Results PR Newswire
Jun-16-14 04:16PM  GENVEC INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits EDGAR Online
May-12-14 05:10PM  U.S./Canada daily earnings hits & misses May 12 - 1710 ET Reuters
09:31AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
08:03AM  GenVec sees FY14 cash burn between $5M-$7M at theflyonthewall.com
08:03AM  GenVec reports Q1 EPS (7c), one estimate 4c at theflyonthewall.com
08:00AM  GenVec Reports First Quarter 2014 Financial Results PR Newswire
Mar-28-14 03:02PM  GenVec's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:00AM  GenVec, Inc. Earnings Call scheduled for 10:00 am ET today CCBN
08:55AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:40AM  GenVec Reports Fourth Quarter and 2013 Year-End Financial Results PR Newswire
07:07AM  Q4 2013 GenVec, Inc. Earnings Release - Before Market Open CCBN
Mar-27-14 05:36PM  Why GenVec (GNVC) Stock Is Up In Aftermarket Trading at TheStreet
Mar-21-14 08:00AM  GenVec To Release Fourth Quarter And Year-End 2013 Financial Results And Conduct A Conference Call On March 28, 2014 PR Newswire
Mar-18-14 05:08PM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
Mar-13-14 08:51AM  GenVec Announces $9 Million Registered Direct Offering PR Newswire
Mar-03-14 08:00AM  GenVec to Present at 26th Annual ROTH Conference PR Newswire
Feb-26-14 07:31AM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Feb-24-14 11:37AM  Coverage initiated on GenVec by HC Wainwright Briefing.com
Feb-13-14 06:15AM  GENVEC INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh EDGAR Online
06:00AM  GenVec Achieves Third Milestone In Hearing And Balance Collaboration PR Newswire
Jan-03-14 07:00AM  3 Biotech Stocks Under $10 Triggering Breakouts at TheStreet
Dec-11-13 04:19PM  GENVEC INC Files SEC form 8-K, Other Events EDGAR Online
Nov-27-13 09:40AM  GENVEC INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of Security EDGAR Online
Nov-12-13 09:52AM  GENVEC INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:50AM  GenVec Reports Third Quarter 2013 Financial Results PR Newswire
GenVec, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of therapeutics and vaccines through its proprietary AdenoVerse gene delivery platform in the United States. It designs, tests, and manufactures adenoviral-based product candidates. The company's lead product candidate, CGF166 is in Phase I/II clinical trials for the treatment of hearing loss and balance disorders. It is also developing GV2311 vaccine for respiratory syncytial virus; and GV2207 vaccine for the treatment of herpes simplex virus. The company has a collaboration agreement with Novartis AG to develop CGF166. It also has collaboration agreement with TheraBiologics, Inc. to develop cancer therapeutics; National Institute of Allergy and Infectious Diseases to create and test various malaria vaccine candidates; and Merial Limited to develop and commercialize vaccine and anti-viral candidates for the prevention and containment of foot-and-mouth diseases in livestock and other animals. The company was founded in 1992 and is based in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swirsky Douglas JPresident & CEODec 14Buy2.005,00010,000242,500Dec 15 09:33 AM
Loren StefanDirectorNov 16Buy1.934,0007,7165,000Nov 18 08:59 AM
Brough Douglas EChief Scientific OfficerAug 11Buy2.344,60010,785136,683Aug 11 04:25 PM